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Abstract
Aims To assess the relationship between body surface area (BSA) at birth and future risk for gestational diabetes mellitus 
(GDM).
Methods This is an observational cohort study from Vantaa, Finland. The cohort included 1548 Finnish primiparous women, 
aged 15–28 years, without pre-existing diabetes, who gave birth 2009–2015. All women were born full-term and had complete 
information about their birth weight and length, from the Finnish Medical Birth Register. Additional data for the study were 
provided by individual patient health records and Statistics Finland. Study participants were divided into five levels (I–V) 
according to BSA at birth, based on normal distribution.
Results There was an inverse association between BSA at birth and risk for GDM (p = 0.015 for linearity, after adjustments 
for age, educational attainment, pre-pregnancy BMI and smoking). The odds ratio (OR) for GDM in level V, with the larg-
est BSA at birth, compared with level I, with the smallest BSA at birth, was 0.43 [95% confidence interval (CI) 0.22–0.83]; 
adjusted for age, educational attainment, pre-pregnancy body mass index and smoking. The OR for GDM was 0.8 (95% CI 
0.68–0.95, p = 0.009) for each one standard deviation increase in BSA at birth, adjusted for the same confounders. BSA at 
birth correlated with adult anthropometry: correlation coefficients were r = 0.16 (95% CI 0.11–0.21) for weight, r = 0.31 
(95% CI 0.26–0.35) for height, and r = 0.06 (95% CI 0.01–0.11) for BMI.
Conclusions Body surface area at birth is inversely associated with future risk for GDM in primiparous women.
Keywords Body surface area at birth · Birth length · Birth weight · Gestational diabetes mellitus
Introduction
Gestational diabetes mellitus (GDM) is a common preg-
nancy disorder and has long been defined as any degree of 
abnormal glucose metabolism, first detected or with first 
onset, during pregnancy [1]. The prevalence of GDM has 
been rising over the last decade [2, 3], making GDM a seri-
ous global health issue today.
Gestational diabetes mellitus has adverse short- and long-
term effects on the pregnant woman and her child, both dur-
ing pregnancy and later in life [4, 5], with maternal obesity 
augmenting the adverse effects on neonatal outcomes [6]. 
Some well-known risk factors for GDM include increase in 
maternal age, genetic predisposition for diabetes mellitus, 
non-Caucasian ethnicity, as well as maternal obesity [7], 
possibly also lifestyle and dietary related factors, paren-
tal smoking and an early age at menarche [7, 8]. A recent 
study emphasizes the importance of recognizing GDM as 
a heterogenic disorder with also non-obese women being 
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affected—indicating the importance of a large number of 
risk factors [9]. Further, studies have shown that maternal 
stature alters glucose metabolism and that short women are 
at increased risk for GDM [10].
According to the Developmental Origins of Health 
and Disease (DOHaD) hypothesis prenatal environmental 
conditions might have long-lasting effects and affect an 
individual´s morbidity in adulthood [11], influencing for 
example the risk for cardiovascular and metabolic distur-
bances [12]. In several previous studies, a negative linear 
association between birth weight and risk for type 2 diabetes 
(T2D) has been observed [13, 14], although some findings 
indicating a U-shaped relationship between birth weight 
and risk of T2D exist [15]. The relationship between birth 
weight and risk for GDM has also been studied. The results 
have been conflicting as both studies indicating an inverse 
association [16–18], as well as a U-shaped relationship have 
been reported [19–21]. However, birth weight is a very crude 
measurement of body size at birth. Interestingly, only one 
recent study has assessed the relationship between maternal 
birth size using ponderal index (PI) as a measurement of 
body size at birth and risk for GDM, showing an inverse 
association [22].
In 2016, we initiated a long-term follow-up study in the 
city of Vantaa, Finland, to assess both short- and long-term 
consequences of glucose metabolism on pregnant women 
and their offspring’s health. The relationship between body 
size at birth and future risk for GDM has previously been 
studied using primarily birth weight as a measure of body 
size at birth. Body surface area (BSA) is an anthropometric 
measurement used to make a more accurate evaluation of 
metabolic mass and body size. The aim of this study is to 
evaluate how BSA at birth affects the future risk for GDM.
Materials and methods
Study population
This is an observational cohort study from the city of Van-
taa, which is part of the Helsinki metropolitan area and the 
fourth biggest city in Finland, with around 220,000 inhabit-
ants. During a 7-year follow-up, between January 1st 2009, 
and December 31st 2015, 13,530 women from Vantaa gave 
birth. Of these, 1548 primiparous women were Finnish (born 
in Finland with Finnish or Swedish as native language), 
without previously diagnosed diabetes mellitus, born at term 
after the year of 1987 (when the Finnish Medical Birth Reg-
ister was founded), and aged 15–28 years during the follow-
up period. All these women had complete data from the birth 
register and thereby formed the study cohort.
Data on maternal-fetal characteristics and pregnancy 
outcomes were obtained from the Finnish Medical Birth 
Register, which is administrated by the National Institute 
for Health and Welfare in Finland and receives the infor-
mation about all live and stillbirths, from 22 gestational 
weeks or an offspring weight of at least 500 g onwards, 
from all Finnish maternity hospitals (http://www.thl.fi/
en/stati stics /partu rient s). The register started to collect 
information on deliveries on a nationwide basis from the 
year 1987. Therefore, only women born 1987 or later were 
included in this study. The following information about 
the women was obtained from this source: their own birth 
weight and birth length, pre-gestational weight in adult-
hood, adult height, previous pregnancies (miscarriages, 
induced abortions or ectopic pregnancies), infertility treat-
ments, information about current pregnancies and deliver-
ies, smoking during pregnancy, and hospitalization due to 
hypertension during pregnancy. Information about GDM, 
height, and weight was further completed by information 
from Vantaa Health care patient records.
Since 2008, the nationwide Finnish Current Care 
Guidelines for GDM recommends screening of all preg-
nant women during their first pregnancy for GDM using 
a standard 2-h 75-g oral glucose tolerance test (OGTT), 
except in women at low risk; that is women with a BMI 
18.5–25 kg/m2, aged under 25 years and with no family 
history of diabetes mellitus [23]. The screening is rou-
tinely performed between gestational weeks 24 and 28, 
except in women at high risk; that is women with a pre-
pregnancy BMI > 35 kg/m2, glucosuria in early pregnancy, 
family history of diabetes, polycystic ovarian syndrome 
(PCOS), or use of oral corticosteroids. In these high-risk 
patients GDM screening is performed earlier in pregnancy 
between gestational weeks 12 and 16, and if OGTT is nor-
mal, it will be repeated between gestational weeks 24 and 
28 [23].
GDM was defined according to the Finnish Current Care 
Guidelines for GDM as one or more pathological glucose 
values in a standard 2-h 75-g OGTT. The diagnostic thresh-
olds were: fasting plasma glucose ≥ 5.3 mmol/L, 1-h glucose 
≥ 10.0 mmol/L, and 2-h glucose ≥ 8.6 mmol/L [23].
Educational attainment was defined according to years 
of schooling, as obtained from Statistics Finland [Official 
Statistics of Finland (OSF): http://www.stat.fi/til/vkour /
index _en.html].
Body size, taking both weight and height into account, 
was calculated as BSA, using mathematical formulas. BSA 
is an anthropometric measurement of interest, in order to 
make a more accurate evaluation of metabolic mass and 
body size as a whole. In our study, BSA at birth was calcu-
lated according to the Meban-BSA formula [24], which in 
2008, as evaluated by Ahn et al., has been proved to be the 
most accurate formula to calculate infant-BSA [25]. Adult 
pre-pregnancy BSA was calculated according to the com-
monly used Mosteller-BSA formula in adults [26].
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Statistical analyses
Data are presented as means with standard deviations (SD) 
or range, or as counts with percentages. The study popu-
lation was divided into five levels according to birth BSA 
levels, based on normal distribution, and corresponding to 
grades containing 12.5, 25, 25, 25, and 12.5% of the total 
distribution. Cut-offs for birth BSA levels were: 2011 cm2 
for level I, 2012–2170 cm2 for level II, 2171–2291 cm2 for 
level III, 2292–2450 cm2 for level IV, and ≥ 2451 cm2 for 
level V. Statistical significances for the unadjusted hypoth-
esis of linearity across categories of birth BSA levels were 
investigated by the Cochran–Armitage test for trend and 
analysis of variance (ANOVA) with an appropriate contrast. 
Adjusted hypotheses of linearity (orthogonal polynomial) 
and the association between birth BSA and GDM prevalence 
were evaluated using logistic models. Models included age, 
educational attainment, pre-pregnancy body mass index, 
and smoking as covariates. By using 5-knot-restricted cubic 
spline regression, a possible nonlinear relationship between 
prevalence of GDM or maternal birth BSA and PI was 
assessed. The length of the distribution of knots was located 
at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles. The 
relationship between birth BSA and pre-pregnancy weight, 
height and BMI was assessed using correlation coefficients 
calculated by the Pearson method. Correlation coefficients 
less than 0.2 were considered very weak, between 0.2 and 
0.4 weak, between 0.4 and 0.6 moderate, between 0.6 and 
0.8 strong, and above 0.8 very strong [27]. The normality 
of the variables was tested using the Shapiro–Wilk W test. 
Statistical significance was set at p < 0.05. Stata 15.0 (Stata-
Corp LP; College Station, TX, USA) statistical package was 
used for the analyses.
Results
Characteristics of the study participants
The mean age of the study participants was 22.4 (SD 2.7) 
years. Baseline characteristics of the 1548 women, divided 
into five levels, according to body surface area (BSA) at 
birth is shown in Table 1. Mean BSA at birth was 2231 cm2 
(SD 191), mean ponderal index was 28.2 kg/m3 (SD 2.5), 
mean birth weight was 3520 g (SD 472), and mean birth 
length was 49.9 cm (SD 2.0), respectively. BSA levels at 
birth showed a positive association with adult pre-pregnancy 
weight, height and BSA (all p < 0.001 for linearity), as well 
as with pre-pregnancy BMI (p = 0.004). There was no sig-
nificant difference between the different BSA groups at 
birth and prevalence of hypertensive disorders during preg-
nancy (p = 0.20). Evaluation of the relationship between 
BSA at birth, and adult pre-pregnancy weight, height and 
pre-pregnancy BMI as continuous values showed an overall 
weak correlation, with the strongest relationship between 
BSA at birth and adult height. The correlation coefficients 
were r = 0.16 [95% confidence interval (CI) 0.11–0.21] for 
pre-pregnancy weight, r = 0.31 (95% CI 0.26–0.35) for adult 
height, and r = 0.06 (95% CI 0.01–0.11) for pre-pregnancy 
BMI (Fig. 1).
BSA at birth and prevalence of GDM
Overall GDM prevalence was 12.3% (95% CI 2.3–14.0). 
BSA at birth was inversely associated with GDM (p = 0.015 
for linearity, after adjustments for age, educational attain-
ment, pre-pregnancy BMI and smoking). The highest preva-
lence of GDM, 18.1% (95% CI 12,7–23,5) was observed 
at level I; whereas, the lowest prevalence of GDM, 9.5% 
was observed at level V (95% CI 5,7–13,3) (Fig. 2). The 
odds ratio (OR) for GDM for those with the largest BSA 
(level V) compared with those with the smallest BSA (level 
I) was 0.43 (95% CI 0.22–0.83) after adjustments for the 
same confounders (Fig. 2). Figure 3 illustrates the continu-
ous relationship between BSA at birth, PI at birth and risk 
for GDM. The OR for GDM was 0.80 (95% CI 0.68–0.95, 
p = 0.009) for each one SD increase in BSA at birth, and the 
OR for GDM was 0.95 (95% CI 0.80–1.12, p = 0.53) for each 
one SD increase in ponderal index at birth, after adjustment 
for the same confounders (Fig. 3).
Discussion
According to our study findings, there is a linear inverse 
association between BSA at birth, and later risk for GDM 
in primiparous women. The prevalence of GDM was highest 
(18.1%), among those with the smallest BSA at birth, and 
lowest (9.5%), among those with the largest BSA at birth. 
Similarly, the OR for GDM in the group with the largest 
BSA, compared to the group with the smallest BSA was 
0.46. We also used another marker of body size at birth, i.e., 
ponderal index to evaluate the relationship between body 
size at birth and risk for GDM. Ponderal index at birth did 
not predict future risk of GDM. Further, BSA at birth and 
adult anthropometry correlated, although weakly, with the 
strongest correlation observed between BSA at birth and 
adult height.
The GDM prevalence in our study cohort was 12% and 
the mean age of the primiparous women was 22 years. The 
mean age of primiparas in Finland during the study period 
between 2010 and 2015 was 29 years [28]. The nationwide 
prevalence of GDM in Finland during 2016 was 18% [28], 
which is higher than the prevalence in the present study. 
This is probably explained by the fact that the women in our 
study cohort were primiparas of rather young age, due to 
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restrictions of our register-based study setting as the data is 
limited to women born after 1987, when the Finnish Medical 
Birth Register was founded.
To the best of our knowledge, this is the first study to 
investigate the relationship between BSA at birth and later 
risk for GDM in primiparous women. We aimed to inves-
tigate the relationship using BSA at birth as a more accu-
rate estimate for body size at birth than for example birth 
weight, in order to approximate the metabolic tissue and 
body size as a whole. Further, we assessed the relationship 
between both BSA and ponderal index as parameters on risk 
for GDM. Comparisons between our findings and previous 
publications are based on studies that have assessed the rela-
tionship between birth weight only or ponderal index, and 
risk for GDM.
Similar to previous studies that have shown birth weight 
to be inversely associated with risk for GDM [16–18, 29, 
30], and a more recent study from 2017 that reported pon-
deral index to be inversely associated with GDM [22], we 
also found an increased risk for GDM in women with a small 
BSA at birth and a lower risk for women with a large BSA 
at birth. However, we did not detect a similar statistically 
significant relationship between ponderal index and risk for 
GDM. Further, we did not detect a U-shaped relationship 
Table 1  Baseline characteristics of 1548 Finnish primiparous women according to body surface area (BSA) at birth
BMI body mass index, BSA body surface area, SD standard deviation
a Included those who quitted smoking during pregnancy
b Hospitalization due to hypertension during pregnancy (including ICD-10 codes O10, O13, and O14)












 BSA  (cm2), mean 
(range)
1910 (1501–2011) 2097 (2012–2170) 2232 (2171–2291) 2362 (2292–2450) 2547 (2451–2972) –
 Birth length (cm), 
mean (SD)
47.1 (1.4) 48.8 (1.2) 50.0 (1.1) 51.1 (1.2) 52.5 (1.3) < 0.001
 Birth weight (g), 
mean (SD)
2755 (203) 3185 (117) 3508 (97) 3836 (122) 4321 (266) < 0.001
 Ponderal index (kg/
m3), mean (SD)
26.4 (2.2) 27.5 (2.4) 28.1 (2.3) 28.9 (2.2) 30.0 (2.4) < 0.001
Maternal adult characteristics
 Age (years), mean 
(SD)
22.3 (2.6) 22.3 (2.8) 22.2 (2.6) 22.7 (2.8) 22.7 (2.7) 0.024
 Cohabiting, n (%) 125 (68) 270 (71) 285 (71) 266 (68) 132 (71) 0.98
 Smokinga, n (%) 66 (36) 127 (33) 152 (38) 127 (32) 55 (30) 0.23
 Years of education, 
mean (SD)
11.3 (1.9) 11.2 (2.1) 11.6 (2.1) 11.8 (2.2) 11.9 (2.1) < 0.001
 Height (cm), mean 
(SD)
162 (6) 164 (5) 165 (5) 166 (6) 169 (6) < 0.001
 Pre-pregnancy 
weight (kg), mean 
(SD)




23.0 (4.2) 23.6 (4.9) 23.5 (4.5) 24.2 (5.2) 24.1 (4.7) 0.005
 BSA  (m2), mean 
(SD)
1.64 (0.18) 1.69 (0.19) 1.71 (0.17) 1.74 (0.21) 1.78 (0.19) < 0.001
 Number of fetuses 
> 1
0 (0) 2 (1) 1 (1) 3 (1) 1 (1) 0.36
 Previous pregnan-
cies
49 (27) 75 (20) 70 (17) 72 (18) 33 (18) 0.043
 Fertility treatment, 
n (%)
3 (2) 10 (3) 6 (1) 7 (2) 4 (4) 0.84
 Hypertensive 
 disordersb, n (%)
16 (9) 24 (6) 16 (4) 21 (5) 11 (6) 0.20
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between small and large infants and risk for GDM, as some 
previous studies have reported with respect to low and high 
birth weight and risk for GDM [19–21, 31, 32].
Fig. 1  Relationship between maternal body surface area (BSA) at birth and maternal anthropometry. The relationship between maternal BSA at 
birth, and maternal adult pre-pregnancy weight, height and BMI shown on scatter plots. BSA body surface area, BMI body mass index
Fig. 2  Prevalence of gestational diabetes mellitus (GDM) accord-
ing to maternal body surface area (BSA) level at birth. Prevalence of 
GDM in percentages (%), according to five different maternal BSA 
levels at birth with the following cut-offs: 2011  cm2 ≤ for level I, 
2012–2170  cm2 for level II, 2171–2291  cm2 for level III, 2292–2450 
 cm2 for level IV, and ≥ 2451  cm2 for level V. p value is calculated for 
linearity across the different levels after adjustments for age, educa-
tional attainment, pre-pregnancy body mass index, and smoking
Fig. 3  Risk for gestational diabetes mellitus (GDM) according to 
standardized maternal body surface area (BSA) at birth and to stand-
ardized maternal ponderal index (PI) at birth. Adjusted odds ratios 
for GDM according to maternal BSA at birth and to maternal pon-
deral index at birth, as standardized values on a continuous scale after 
adjustments for age, educational attainment, pre-pregnancy BMI, and 
smoking. Reference values are the average values of BSA and PI in 
the study cohort (standardized Z-score values at 0). The curves were 
derived from 5-knot-restricted cubic spline logistic models. Gray 
areas and whiskers represent 95% confidence intervals. BMI body 
mass index
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The conflicting results between former studies with 
regard to a linear inverse versus a U-shaped relationship 
between birth weight and risk for GDM have, at least to 
some extent, been thought to reflect differences in study set-
tings, with some studies lacking a big enough comparison 
group of macrosomic infants. In addition, the relationship 
has also been explained by ethnic differences; as Williams 
showed in 1999, women of African-American ethnicity 
showed a U-shaped relationship between birth weight and 
risk for GDM, while women of other ethnicities, showed an 
inverse linear relationship [33]. Moreover, offspring born to 
pregnant women who have been diagnosed with GDM are 
more prone to be macrosomic, and maternal GDM has been 
recognized as a risk factor for future metabolic disturbances 
in the offspring [5].
There are several factors affecting fetal growth such as 
gestational age, parity, infant sex, in utero metabolism, and 
genetic factors [34, 35]. Furthermore, a small body size at 
birth can be explained by malnutrition during pregnancy 
[36], or maternal constraints [37], due to limited space in 
utero as a result of a narrow pelvis.
A small birthweight has been thought to affect morbid-
ity in adulthood and has formed the basis for the DOHaD 
hypothesis [38]—the concept that the in utero environment, 
developmental plasticity, and possible epigenetic mecha-
nisms during critical periods of early organ development can 
have long-lasting effects on health [38]. Moreover, low birth 
weight has been linked to insulin resistance [39]. In 1991, 
Hales and Barker proposed in their Hertfordshire study that 
infants born small have an impaired glucose tolerance in 
adulthood and that this might be due to impaired develop-
ment of the endocrine pancreas and result in impaired beta 
cell function later in life [40]. Further, insulin is recognized 
to be an important growth factor and studies indicate that 
there could be genetic alleles that might both reduce fetal 
growth and cause an impaired insulin secretion and hence, 
predispose to diabetes [41].
Why did we think it was important to assess the relation-
ship between maternal body size as a whole, also taking 
birth length into account, and risk for GDM? Compared to 
birth weight, birth length has been considered to be an even 
stronger predictor of adult height [42, 43], and height has 
been shown to influence the risk for GDM [10].
In 2005, Eide et al. concluded that as birth length predicts 
adult stature and adult stature is associated with several non-
communicable disorders—birth length might be a better pre-
dictor of adult health than birth weight [42]. Adult weight is 
to a greater degree influenced by environmental factors and 
appears to have a weaker hereditary component than height 
[42]. Therefore, in order to have a more accurate measure-
ment of maternal body size at birth, taking both birth weight 
and birth length into account and to further dilute the effect 
of birth weight as the only measurement of birth size in 
assessing the risk of disease burden in adulthood, we wanted 
to evaluate the risk for GDM using both BSA and ponderal 
index at birth as measurements. According to our results, 
BSA has a stronger effect on predicting risk for GDM than 
ponderal index has. Our findings suggest that risk for GDM 
is inversely associated with BSA at birth. Ponderal index at 
birth showed no significant effect on risk for GDM.
The strength of the study is that it encompasses all primi-
parous Finnish women from Vantaa city, the fourth biggest 
city in Finland, who delivered during a 7-year follow-up 
period and of whom we had complete data about their own 
birth length and weight based on register data. To avoid the 
confounding effect of previous GDM or parity, we included 
only primiparas in the study. The diagnosis of GDM is based 
on a standardized 2-h 75-g OGTT and the diagnostic crite-
ria have remained the same during the whole study period. 
Finally, the Finnish Medical Birth Register is considered to 
be of high quality [44].
The study also has some limitations. We missed informa-
tion about some well-known risk factors for GDM; such as 
family history of diabetes, gestational weight gain, dietary 
habits, and physical activity. All study participants had 
Finnish background, and therefore the generalization of 
the results globally can be restricted. Most importantly, it 
was only in 1987 when the Finnish Medical Birth Register 
started to collect information on a nationwide basis, thereby, 
this cohort consisted only of rather young primiparas and 
the results cannot be generalized to older pregnant women.
In conclusion, BSA at birth is inversely associated with 
future risk for GDM in primiparous women. Special atten-
tion should be paid to pregnant women who have been born 
small, in order to follow-up and if possible reduce the risk 
for GDM. Likewise, to encourage a healthy and nutritious 
pregnancy diet and to aim for an optimal fetal growth are 
important in any pregnancy to reduce transgenerational 
transmission of GDM and to prevent an infant’s risk for 
being born small and thereby at risk for future metabolic 
disturbances.
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